Stocks · Health care · Pharmaceutical Preparations

ZEVRA THERAPEUTICS, INC.

ZVRA Clue Score60
United States Fiscal year ends December CIK 0001434647 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
John B Bode
24 Mar 2026
Director
Exercised, kept
39,200
$4.89
$191.69K
John B Bode
24 Mar 2026
Director
Exercised, kept
39,200
$4.97
$194.82K

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 5
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 754,713
History held since 17 Apr 2015